SCIENTURE HOLDINGS, INC. Notes Issued
SCIENTURE HOLDINGS, INC. (SCNX) reported Notes Issued of $500.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:NotesIssued1 · last filed 2025-05-12
- SCIENTURE HOLDINGS, INC. notes issued for the quarter ending 2024-03-31 was $500.00K, a 0.00% change year-over-year.
- SCIENTURE HOLDINGS, INC. notes issued for the quarter ending 2023-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. notes issued for the quarter ending 2023-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. notes issued for the quarter ending 2023-06-30 was $0.00.
- SCIENTURE HOLDINGS, INC. notes issued for fiscal 2023 was $500.00K, a 0.00% change from fiscal 2022.
- SCIENTURE HOLDINGS, INC. notes issued for fiscal 2022 was $500.00K.
- SCIENTURE HOLDINGS, INC. notes issued for fiscal 2017 was $16.50K, a 10.00% increase from fiscal 2016.
- SCIENTURE HOLDINGS, INC. notes issued for fiscal 2016 was $15.00K.
| Period end | Notes Issued 3 month | Notes Issued 6 month | Notes Issued 9 month | Notes Issued 12 month |
|---|---|---|---|---|
| 2024-03-31 | $500.00K 10-Q · filed 2025-05-12 | $500.00K derived: sum of 2 quarters · filed 2025-05-12 | $500.00K derived: sum of 3 quarters · filed 2025-05-12 | $500.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $0.00 derived: sum of 2 quarters · filed 2025-03-26 | $0.00 derived: sum of 3 quarters · filed 2025-03-26 | $500.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $500.00K 10-Q · filed 2024-11-06 | $500.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $500.00K 10-Q · filed 2024-08-09 | $500.00K derived: sum of 3 quarters · filed 2024-08-09 | $500.00K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $500.00K 10-Q · filed 2024-06-26 | $500.00K derived: sum of 2 quarters · filed 2024-06-26 | $500.00K derived: sum of 3 quarters · filed 2024-06-26 | $500.00K derived: sum of 4 quarters · filed 2024-06-26 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | $0.00 derived: sum of 2 quarters · filed 2024-04-22 | $0.00 derived: sum of 3 quarters · filed 2024-04-22 | $500.00K 10-K · filed 2024-04-22 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-16 | $0.00 derived: sum of 2 quarters · filed 2024-01-16 | $500.00K 10-Q · filed 2024-01-16 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-18 | $500.00K 10-Q · filed 2023-08-18 | ||
| 2022-03-31 | $500.00K 10-Q · filed 2022-05-09 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $0.00 derived: sum of 2 quarters · filed 2018-03-02 | $16.50K 10-K · filed 2018-03-02 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $16.50K 10-Q · filed 2017-11-07 | ||
| 2017-06-30 | $16.50K 10-Q · filed 2017-08-04 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $0.00 derived: sum of 2 quarters · filed 2018-03-02 | $15.00K 10-K · filed 2018-03-02 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $15.00K 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $15.00K 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |